KORU Medical Systems, Inc. Income Statement
KRMD|12 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$34M
FY2025
Gross Profit
$21M
63.4% gross margin
Operating Income
-$6M
FY2025
Net Income
-$6M
FY2025
KORU Medical Systems, Inc. reported $34M in revenue and $6M in net loss for FY2025. Revenue has grown at a 14.7% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2017 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.6M | $28.5M | $27.9M | $23.5M | $24.2M | $23.2M | $17.4M | $12.2M | $11.2M | $7.8M | $6.4M | $4.9M |
| Cost of Revenue | $12.3M | $11.8M | $12.5M | $9.7M | $9.2M | $8.3M | $6.5M | $4.6M | $4.6M | $2.8M | $2.3M | $1.7M |
| Gross Profit | $21.3M | $16.7M | $15.4M | $13.8M | $14.9M | $14.9M | $10.8M | $7.6M | $6.7M | - | - | - |
| SG&A Expense | $21.6M | $20.4M | $20.6M | $17.9M | $12.0M | $9.8M | $8.2M | $5.9M | $4.8M | $3.5M | $2.7M | $2.0M |
| R&D Expense | $5.3M | $5.7M | $5.0M | $2.5M | $1.3M | $740.5K | $241.1K | $207.3K | $468.2K | $147.6K | $90.3K | $35.5K |
| Operating Income | -$6.4M | -$10.3M | -$10.8M | -$7.0M | -$1.3M | $585.7K | $1.2M | $1.2M | $1.1M | $1.1M | $1.3M | $1.2M |
| Interest Expense | - | - | - | - | - | - | - | $3.4K | $512 | $28.3K | $31.5K | $36.4K |
| Income Tax | $2.9K | $4.0M | -$2.0M | -$1.8M | -$17.8K | $132.1K | $266.4K | $359.7K | $321.4K | $312.3K | $465.3K | $489.0K |
| Net Income | -$6.1M | -$13.7M | -$8.7M | -$4.6M | -$1.2M | $564.3K | $910.6K | $782.9K | $753.1K | $725.8K | $815.9K | $704.1K |
| EPS (Basic) | -$0.13 | -$0.30 | -$0.19 | -$0.10 | -$0.03 | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 |
| EPS (Diluted) | -$0.13 | -$0.30 | -$0.19 | -$0.10 | -$0.03 | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 |
| Shares Outstanding | 46.0M | 45.7M | 45.4M | 44.6M | 43.3M | 39.5M | 38.2M | 37.8M | 38.0M | 36.7M | 35.2M | 34.3M |
| Gross Margin | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% | 64.1% | 62.3% | 62.1% | 59.5% | - | - | - |
| Operating Margin | -19.2% | -36.0% | -38.6% | -29.9% | -5.2% | 2.5% | 6.7% | 9.7% | 10.2% | 13.7% | 20.2% | 24.3% |
| Profit Margin | -18.0% | -48.2% | -31.1% | -19.4% | -5.0% | 2.4% | 5.3% | 6.4% | 6.7% | 9.3% | 12.8% | 14.3% |